FibroBiologics Inc. Company Profile
NASDAQ: FBLGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 1.12 -0.88%
FibroBiologics at a glance
FibroBiologics Inc. (NASDAQ: FBLG) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Houston, TX. FibroBiologics is led by Mr. Peter O'Heeron and employs about 15 people. At a market capitalization of $7.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001958777, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does FibroBiologics do?
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Business description based on the company's public filings.
Company information
- Legal name
- FibroBiologics Inc.
- Ticker
- NASDAQ: FBLG
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Peter O'Heeron
- Employees
- 15
- Headquarters
- 455 East Medical Center Boulevard, Houston, TX, United States
- Phone
- 281 671 5150
- Website
- fibrobiologics.com
- Market cap
- $7.59M
- SEC CIK
- 0001958777
- Latest annual report
- 10-K/A · Mar 13, 2026
Companies similar to FibroBiologics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| APUSApimeds Pharmaceuticals US Inc. | 5.02 | -8.89% | $7.58M | vs FBLG |
| APREAprea Therapeutics Inc. | 0.6044 | +8.28% | $7.61M | vs FBLG |
| SKYESkye Bioscience Inc. | 1.69 | +0.60% | $7.48M | vs FBLG |
| INMInMed Pharmaceuticals Inc. | 1.36 | +2.26% | $7.47M | vs FBLG |
| CNSPCNS Pharmaceuticals Inc. | 5.35 | 0.00% | $7.82M | vs FBLG |
| AZTRAzitra Inc | 0.1299 | -1.59% | $7.87M | vs FBLG |
| LGVNLongeveron Inc. Class A | 2.48 | +4.64% | $7.91M | vs FBLG |
| SNGXSoligenix Inc. | 0.3636 | +4.90% | $7.91M | vs FBLG |